Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for stroke: 2006 overview.

Yi Chu1, Jordan D Miller, Donald D Heistad

  • 1Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242, USA.

Current Hypertension Reports
|March 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CT-based radiomics to predict peri-device leakage after left atrial appendage closure.

BMC medical imaging·2026
Same author

pKAKA: a protein language model for prioritizing kinase-disrupting variants in diseases.

Journal of genetics and genomics = Yi chuan xue bao·2026
Same author

Identification of a nucleotide deletion at the flanking sequence of D12S391 that causes allelic imbalance and inter-kit discordance.

Forensic science international·2026
Same author

RYGB induces vagal sensory neuropathy characterized by altered Glp1r expression and enhanced exendin-4 responsiveness in male mice.

American journal of physiology. Endocrinology and metabolism·2025
Same author

Endothelial senescent-cell-specific clearance alleviates metabolic dysfunction in obese mice.

Cell metabolism·2025
Same author

In Memoriam: Allyn L. Mark.

Hypertension (Dallas, Tex. : 1979)·2025
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

Gene therapy shows promise for cerebrovascular diseases like stroke. Research explores using gene transfer for neuroprotection and preventing vasospasm, with advances in safer vectors.

Area of Science:

  • Neurology
  • Molecular Biology
  • Biotechnology

Background:

  • Gene therapy offers potential for treating stroke and other cerebrovascular diseases.
  • Therapeutic strategies include pre-stroke plaque stabilization and post-stroke interventions like preventing vasospasm and reducing ischemic injury.

Purpose of the Study:

  • To review recent developments in experimental gene therapy for stroke.
  • To discuss advances in gene transfer vectors for cerebrovascular applications.

Main Methods:

  • Gene transfer of vasoactive calcitonin gene-related peptide via cerebrospinal fluid.
  • Exploration of neuroprotective gene transfer and small interfering RNA for neurotoxic genes.
  • Review of advancements in gene transfer vector safety and specificity.

Related Experiment Videos

Main Results:

  • Demonstrated attenuation of vasospasm after subarachnoid hemorrhage (SAH) using calcitonin gene-related peptide gene transfer.
  • Identified potential for neuroprotective gene therapy and RNA interference in ischemic stroke treatment.

Conclusions:

  • Gene therapy holds significant promise for stroke treatment, though clinical realization may be distant.
  • Development of safer and more specific gene transfer vectors is crucial for advancing stroke gene therapy.